STOCK TITAN

[RW] BIOSTEM TECHNOLOGIES SEC Filing

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
RW

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Accepted by SEC EDGAR Learn about SEC filing dates

BIOSTEM TECHNOLOGIES, INC.

2836 Center Port Circle

Pompano Beach, FL 33064

October 28, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549-3561

 

Attention:    Eric Atallah
   Angela Connell
   Laura Crotty
   Tamika Sheppard
   Suzanne Hayes

 

Re:

Biostem Technologies

Application for Withdrawal of Registration Statement on Form 10-12(b)

Initially filed September 27, 2024

File No. 001-42292

Ladies and Gentlemen:

Pursuant to Rule 477 under the Securities Act of 1933, as amended, BioStem Technologies, Inc., a Florida corporation (the “Company”), hereby requests withdrawal of the Company’s Registration Statement on Form 10, initially filed with the Commission on September 27, 2024, together with all exhibits and amendments thereto (the “Registration Statement”). The Company is in the process of revising its registration statement and accompanying financial statements to adequately address certain comments received from the Commission. No securities were sold in connection with the Registration Statement.

It is our understanding that this application for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the Commission unless, within fifteen days after such date, the Company receives notice from the Commission that this application will not be granted.

If you have any questions or comments with respect to this matter, please call counsel for the Company, Flora Perez, at (954) 768-8210.

 

Very truly yours,
BioStem Technologies, Inc.
By:  

/s/ Jason Matuszewski

  Name: Jason Matuszewski
  Title: Chairman and Chief Executive Officer

Keep reading